- Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
-
Kamei H, Yamada H, Hatano M, Hanya M, Yamada S, Iwata N
- KMID: 2502138
- Clin Psychopharmacol Neurosci.
- 2020 Feb;18(1):159-163.
- doi: 10.9758/cpn.2020.18.1.159
In Japan, drug therapy for schizophrenia is characterized by high-dose antipsychotic polypharmacy, which is an uncommon approach internationally. In this study, we reduced the number of antipsychotic agents in 5... -
- CITED
-
- Close
- SHARE
-
- Close
- Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia
-
Kamei H, Homma Y, Takeuchi I, Hajitsu G, Tozawa K, Hatano M, Fukui A, Hanya M, Yamada S, Iwata N
- KMID: 2502126
- Clin Psychopharmacol Neurosci.
- 2020 Feb;18(1):49-57.
- doi: 10.9758/cpn.2020.18.1.49
Objective: To improve poor medication adherence in schizophrenic patients, long-acting injectable (LAI) antipsychotics are used. However, it has not yet become common in Japan. Recently, aripiprazole LAI was approved for... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
-
Hatano M, Kamei H, Inagaki R, Matsuzaki , Hanya M, Yamada S, Iwata N
- KMID: 2412387
- Clin Psychopharmacol Neurosci.
- 2018 May;16(2):184-189.
- doi: 10.9758/cpn.2018.16.2.184
OBJECTIVE: Suvorexant is a novel hypnotic drug that does not interact with the conventional γ-aminobutyric acid (GABA)-A receptor. We investigated the method by which suvorexant was introduced in insomnia patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan
-
Hatano M, Takeuchi I, Yamashita K, Morita A, Tozawa K, Sakakibara T, Hajitsu G, Hanya M, Yamada S, Iwata N, Kamei H
- KMID: 2522958
- Clin Psychopharmacol Neurosci.
- 2021 Nov;19(4):610-617.
- doi: 10.9758/cpn.2021.19.4.610
Objective: To identify factors affecting adherence to medication, a subjective questionnaire survey was administered to schizophrenia patients regarding the prescribed antipsychotic formulations. Methods: We evaluated the patients’ satisfaction and dissatisfaction with... -
- CITED
-
- Close
- SHARE
-
- Close
- Validity and Reliability of Seattle Angina Questionnaire Japanese Version in Patients With Coronary Artery Disease
-
Seki S, Kato N, Ito N, Kinugawa K, Ono M, Motomura N, Yao A, Watanabe M, Imai Y, Takeda N, Inoue M, Hatano M, Kazuma K
- KMID: 2268210
- Asian Nurs Res.
- 2010 Jun;4(2):57-63.
PURPOSE: The aim of this study was to evaluate the validity and reliability of the Seattle Angina Questionnaire, Japanese version (SAQ-J) as a disease-specific health outcome scale in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia
-
Hatano M, Kamei H, Kato A, Takeuchi I, Hanya M, Uno J, Yamada S, Fujita K, Iwata N
- KMID: 2378481
- Clin Psychopharmacol Neurosci.
- 2017 May;15(2):132-137.
- doi: 10.9758/cpn.2017.15.2.132
OBJECTIVE: The adverse effects of antipsychotic agents can have a marked influence on medication adherence. In this study, we investigated the adverse events of antipsychotics that are less likely to... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimizing preoperative bone health assessment for adult spinal deformity: a prospective correlation analysis of intraoperative pedicle screw insertion torque and imaging modalities in Japan
-
Maruo K, Arizumi F, Kusukawa T, Toi M, Hatano M, Yamaura T, Kishima K, Tachibana T
- KMID: 2558826
- Asian Spine J.
- 2024 Aug;18(4):532-540.
- doi: 10.31616/asj.2023.0443
Study Design: Prospective cohort study. Purpose: This study aimed to identify the optimal preoperative bone health assessment for adult spinal deformity (ASD) surgery through correlation analysis between intraoperative pedicle screw (PS)... -
- CITED
-
- Close
- SHARE
-
- Close
